Vimta Labs Limited

NSE VIMTALABS.NS

Vimta Labs Limited Operating Cash Flow for the year ending March 31, 2024: USD 7.30 M

Vimta Labs Limited Operating Cash Flow is USD 7.30 M for the year ending March 31, 2024, a -31.77% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Vimta Labs Limited Operating Cash Flow for the year ending March 31, 2023 was USD 10.70 M, a 37.53% change year over year.
  • Vimta Labs Limited Operating Cash Flow for the year ending March 31, 2022 was USD 7.78 M, a 53.20% change year over year.
  • Vimta Labs Limited Operating Cash Flow for the year ending March 31, 2021 was USD 5.08 M, a 57.16% change year over year.
  • Vimta Labs Limited Operating Cash Flow for the year ending March 31, 2020 was USD 3.23 M, a -42.64% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
Loading...
SV Wall Street
NSE: VIMTALABS.NS

Vimta Labs Limited

CEO Dr. Sivalinga Prasad Vasireddi
IPO Date Dec. 15, 2005
Location India
Headquarters Plot Nos. 141/2 & 142, IDA, Phase II
Employees 1,428
Sector Health Care
Industries
Description

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Similar companies

VISAKAIND.NS

Visaka Industries Limited

USD 1.02

6.17%

RPGLIFE.NS

RPG Life Sciences Limited

USD 28.13

1.29%

UNICHEMLAB.NS

Unichem Laboratories Limited

USD 8.15

-0.17%

GUFICBIO.NS

Gufic Biosciences Limited

USD 5.19

6.71%

VENUSREM.NS

Venus Remedies Limited

USD 3.47

1.60%

StockViz Staff

February 1, 2025

Any question? Send us an email